NU vs. PFE

Last updated Apr 9, 2026

NU (Nu Holdings Ltd.) is a stock, while PFE (Pfizer Inc.) is a stock. Over the past 3 years, NU returned 47.96%/yr vs -7.43%/yr for PFE. At 0.06, their price movements are largely independent.

Performance

NU vs. PFE - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Nu Holdings Ltd. (NU) and Pfizer Inc. (PFE). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, NU achieves a -13.32% return, which is significantly lower than PFE's 12.17% return.

NU

• 1D: 2.54%
• 1M: -1.09%
• YTD: -13.32%
• 6M: -6.14%
• 1Y: 45.54%
• 3Y*: 47.96%
• 5Y*: —
• 10Y*: —

PFE

• 1D: 1.37%
• 1M: 2.46%
• YTD: 12.17%
• 6M: 10.68%
• 1Y: 34.91%
• 3Y*: -7.43%
• 5Y*: -0.74%
• 10Y*: 3.28%

*Multi-year figures are annualized to reflect compound growth (CAGR)

NU vs. PFE - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021
NU Nu Holdings Ltd.	-13.32%	61.58%	24.37%	104.67%	-56.61%	-9.20%
PFE Pfizer Inc.	12.17%	0.65%	-2.22%	-41.26%	-10.41%	13.38%

Correlation

The correlation between NU and PFE is 0.11, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.11
Correlation (3Y) Calculated over the trailing 3-year period	0.09
Correlation (All Time) Calculated using the full available price history since Dec 10, 2021	0.06

Fundamentals

Market Cap NU : $71.34B PFE : $156.19B
EPS NU : $0.58 PFE : $1.36
PE Ratio NU : 24.82 PFE : 20.16
PEG Ratio NU : 0.38 PFE : 0.36
PS Ratio NU : 4.63 PFE : 2.50
PB Ratio NU : 6.32 PFE : 1.68
Total Revenue (TTM) NU : $15.40B PFE : $62.58B
Gross Profit (TTM) NU : $6.61B PFE : $44.01B
EBITDA (TTM) NU : $3.94B PFE : $15.10B

Return for Risk

NU vs. PFE — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

NU

NU Risk / Return Rank: 66
NU Sharpe Ratio Rank: 67
NU Sortino Ratio Rank: 61
NU Omega Ratio Rank: 61
NU Calmar Ratio Rank: 69
NU Martin Ratio Rank: 72

PFE

PFE Risk / Return Rank: 71
PFE Sharpe Ratio Rank: 72
PFE Sortino Ratio Rank: 68
PFE Omega Ratio Rank: 64
PFE Calmar Ratio Rank: 76
PFE Martin Ratio Rank: 74

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

NU vs. PFE - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Nu Holdings Ltd. (NU) and Pfizer Inc. (PFE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	NU	PFE	Difference
Sharpe ratio Return per unit of total volatility	1.17	1.36	-0.19
Sortino ratio Return per unit of downside risk	1.71	2.02	-0.32
Omega ratio Gain probability vs. loss probability	1.23	1.25	-0.02
Calmar ratio Return relative to maximum drawdown	1.83	2.46	-0.64
Martin ratio Return relative to average drawdown	5.17	5.68	-0.51
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

NU vs. PFE - Sharpe Ratio Comparison

The current NU Sharpe Ratio is 1.17, which is comparable to the PFE Sharpe Ratio of 1.36. The chart below compares the historical Sharpe Ratios of NU and PFE, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	NU	PFE	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	1.17	1.36	-0.19
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	—	-0.03	—
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	0.14	—
Sharpe Ratio (All Time) Calculated using the full available price history	0.14	0.26	-0.12

Drawdowns

NU vs. PFE - Drawdown Comparison

The maximum NU drawdown since its inception was -72.07%, which is greater than PFE's maximum drawdown of -58.96%. Use the drawdown chart below to compare losses from any high point for NU and PFE.

Drawdown Indicators

	NU	PFE	Difference
Max Drawdown Largest peak-to-trough decline	-72.07%	-58.96%	-13.11%
Max Drawdown (1Y) Largest decline over 1 year	-27.99%	-11.47%	-16.52%
Max Drawdown (5Y) Largest decline over 5 years	—	-58.96%	—
Max Drawdown (10Y) Largest decline over 10 years	—	-58.96%	—
Current Drawdown Current decline from peak	-22.65%	-44.00%	+21.35%
Average Drawdown Average peak-to-trough decline	-29.87%	-17.36%	-12.51%
Ulcer Index Depth and duration of drawdowns from previous peaks	9.88%	4.97%	+4.91%

Volatility

NU vs. PFE - Volatility Comparison

Nu Holdings Ltd. (NU) has a higher volatility of 12.19% compared to Pfizer Inc. (PFE) at 7.18%. This indicates that NU's price experiences larger fluctuations and is considered to be riskier than PFE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	NU	PFE	Difference
Volatility (1M) Calculated over the trailing 1-month period	12.19%	7.18%	+5.01%
Volatility (6M) Calculated over the trailing 6-month period	27.30%	16.10%	+11.20%
Volatility (1Y) Calculated over the trailing 1-year period	39.42%	26.19%	+13.23%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	59.03%	25.52%	+33.51%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	59.03%	23.86%	+35.17%

Dividends

NU vs. PFE - Dividend Comparison

NU has not paid dividends to shareholders, while PFE's dividend yield for the trailing twelve months is around 6.26%.

	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
NU Nu Holdings Ltd.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
PFE Pfizer Inc.	6.26%	6.91%	6.33%	5.70%	3.12%	2.64%	3.92%	3.68%	3.12%	3.53%	3.69%	3.47%

Financials

NU vs. PFE - Profitability Comparison

The chart below illustrates the profitability comparison between Nu Holdings Ltd. and Pfizer Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

NU - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Nu Holdings Ltd. reported a gross profit of 2.09B and revenue of 4.70B. Therefore, the gross margin over that period was 44.3%.

PFE - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Pfizer Inc. reported a gross profit of 12.29B and revenue of 17.56B. Therefore, the gross margin over that period was 70.0%.

NU - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Nu Holdings Ltd. reported an operating income of 1.08B and revenue of 4.70B, resulting in an operating margin of 22.9%.

PFE - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Pfizer Inc. reported an operating income of 3.69B and revenue of 17.56B, resulting in an operating margin of 21.0%.

NU - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Nu Holdings Ltd. reported a net income of 892.38M and revenue of 4.70B, resulting in a net margin of 19.0%.

PFE - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Pfizer Inc. reported a net income of -1.65B and revenue of 17.56B, resulting in a net margin of -9.4%.